Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
about
Cytomegalovirus after kidney transplantation: a case review.Five-year safety and efficacy of belatacept in renal transplantationLack of economic benefit with basiliximab induction in living related donor adult renal transplant recipients.Emerging trends in infections among renal transplant recipients.Latent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients.The impact of cytomegalovirus infection ≥1 year after primary renal transplantation.Donor Characteristics of Pancreas Transplantation in Australia and New Zealand: A Cohort Study 1984-2014Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.Simultaneous pancreas/kidney transplant recipients are predisposed to tissue-invasive cytomegalovirus disease and concomitant infectious complications.Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients.Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis.Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation.Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus.Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival.
P2860
Q30437363-5E7A8D6D-BFEE-4BBB-885F-B7381C2E15A5Q34621558-F94F2DAD-E4C1-436E-A553-5A07778FB32EQ35101460-3E4AC80C-0916-4F51-97A5-A754804F0A7FQ35917332-C0EF7B73-4639-4B38-8923-38678845E43EQ36516318-3C8722EF-F8D3-4E79-AF32-67EE06639EA5Q36558077-5124D303-C7EF-43B4-B41C-992EF7EB01FAQ37346590-05848F9F-9F25-4D2E-875F-FEB3C1D5BF48Q37680941-DBE38010-AF18-4B34-A511-04E1FF2B9993Q40139857-538EE84B-4C40-4B5A-87C7-921991671043Q42260511-E6AF7051-288A-408C-8588-7F61D6C22C29Q44079966-E13BA833-F3A2-46DB-9A2E-F2B006F2A7C7Q44461493-32B18FD2-D998-445A-A561-1D8CD967EE6CQ44963388-E44C8F9C-256A-4561-A047-5B501B4023C2Q45289899-7514504C-A375-4CD5-9DD9-9A2EAF089ACCQ46733515-82C5568B-3205-4136-BAAC-7BCC29D50D79
P2860
Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Reassessing the impact of cyto ...... dney-pancreas transplantation.
@en
Reassessing the impact of cyto ...... dney-pancreas transplantation.
@nl
type
label
Reassessing the impact of cyto ...... dney-pancreas transplantation.
@en
Reassessing the impact of cyto ...... dney-pancreas transplantation.
@nl
prefLabel
Reassessing the impact of cyto ...... dney-pancreas transplantation.
@en
Reassessing the impact of cyto ...... dney-pancreas transplantation.
@nl
P2093
P356
P1476
Reassessing the impact of cyto ...... dney-pancreas transplantation.
@en
P2093
Bryan N Becker
Glen E Leverson
Hans W Sollinger
John D Pirsch
William D Simmons
Yolanda T Becker
P304
P356
10.1053/AJKD.2002.32793
P577
2002-05-01T00:00:00Z